ANI PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.5 USD | +0.21% |
|
-0.18% | +18.79% |
| Apr. 17 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
| Apr. 09 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
Chart calendar ANI Pharmaceuticals, Inc.
8a23be94ef77d9febb5c4df3.t2YSjqw9SRvLj2W0TE4E2O4n9rZkKIuC7eVb8hlvSsI.hgklv8QEJ0mE9iKZDwh8gcNTpoQhUO3Tn4hpoUMMAbjCKU3kxno6cYzfJA~de67ee515de7c9301f80ae21819afdea
Upcoming events on ANI Pharmaceuticals, Inc.
Past events on ANI Pharmaceuticals, Inc.
| 2024-04-16 | Piper Sandler Spring Biopharma Symposium |
| 2024-03-12 02:20 pm | Leerink Partners Global Biopharma Conference |
| 2024-02-29 08:30 am | Q4 2023 Earnings Call |
| 2024-02-29 06:50 am | Q4 2023 Earnings Release |
| 2024-02-08 10:30 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-11-28 01:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-15 10:00 am | Jefferies London Healthcare Conference |
| 2023-11-08 08:30 am | Q3 2023 Earnings Call |
| 2023-11-08 06:50 am | Q3 2023 Earnings Release |
| 2023-09-26 11:40 am | Cantor Global Healthcare Conference |
| 2023-09-12 08:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-09 08:30 am | Q2 2023 Earnings Call |
| 2023-08-09 06:50 am | Q2 2023 Earnings Release |
| 2023-06-09 08:30 am | Jefferies Global Healthcare Conference |
| 2023-05-23 09:00 am | Annual General Meeting |
| 2023-05-08 08:30 am | Q1 2023 Earnings Call |
| 2023-05-08 06:50 am | Q1 2023 Earnings Release |
| 2023-05-02 12:00 pm | H.C. Wainwright BioConnect Investor Conference |
| 2023-03-09 08:30 am | Q4 2022 Earnings Call |
| 2023-03-09 06:50 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 207 210 -1.85% | 208 205 1.51% | 216 212 2.14% | 316 308 2.89% | 487 480 1.42% | 535 |
|
EBITDA Million USD | Released Forecast Spread | 83,2 85,5 -2.74% | 67,1 68,0 -1.3% | 64,8 64,8 0.06% | 55,9 54,1 3.26% | 134 133 0.87% | 140 |
|
EBIT Million USD | Released Forecast Spread | 16,4 26,4 -38.06% | -16,0 -11,4 -40.49% | -39,8 -17,1 -132.71% | -35,3 -34,0 -3.77% | 47,0 49,5 -5.19% | 51,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,16 13,2 -76.08% | -26,0 -20,9 -24.22% | -56,1 -28,4 -97.39% | -62,7 -61,4 -2.13% | 19,9 21,8 -8.95% | 28,8 |
|
Net income Million USD | Released Forecast Spread | 6,09 12,8 -52.39% | -22,5 -16,9 -33.42% | -42,8 -20,9 -104.75% | -49,5 -47,9 -3.32% | 17,2 19,9 -13.99% | 22,9 |
|
EPS USD | Released Forecast Spread | 0,50 1,06 -52.83% | -1,88 -1,41 -33.33% | -3,40 -0,88 -288.57% | -3,05 -2,94 -3.86% | 0,85 0,92 -7.61% | 1,29 |
| Announcement Date | 27/02/20 | 09/03/21 | 15/03/22 | 09/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,9 56,3 8.22% | 64,5 65,0 -0.86% | 73,9 72,0 2.62% | 83,8 78,4 6.97% | 94,2 86,1 9.4% | 107 83,5 27.92% | 117 99,9 16.71% | 132 112 17.79% | 132 125 5.38% | 126 | 131 | 137 | 141 | 133 |
|
EBITDA Million USD | Released Forecast Spread | 16,2 16,6 -2.39% | 4,27 7,70 -44.51% | 9,86 9,50 3.8% | 19,6 19,5 0.52% | 23,3 23,2 0.56% | 33,0 16,4 101.3% | 34,1 22,8 49.51% | 36,5 27,5 32.55% | 30,2 28,3 6.59% | 30,5 | 33,5 | 37,0 | 38,8 | 36,4 |
|
EBIT Million USD | Released Forecast Spread | -23,7 -1,10 -2056.64% | -19,2 -9,30 -106.4% | -12,9 -9,10 -41.9% | -5,00 0,40 -1348.75% | 1,82 3,10 -41.29% | 9,90 -1,30 861.15% | 12,4 1,96 531.79% | 17,9 7,41 142.28% | 6,73 7,55 -10.91% | 8,86 | 11,7 | 14,5 | 16,2 | 14,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,9 -3,20 -864.16% | -25,9 -15,4 -68.16% | -18,8 -15,0 -25.45% | -12,2 -5,20 -135.04% | -5,73 -3,00 -90.93% | 2,17 -9,30 123.28% | 5,25 -5,04 204.21% | 11,5 0,31 3637.34% | 0,95 1,15 -17.69% | 3,09 | 6,10 | 8,95 | 10,8 | 8,89 |
|
Net income Million USD | Released Forecast Spread | -24,3 -2,40 -913.58% | -20,5 -11,9 -72.56% | -15,3 -11,3 -35.66% | -9,01 -4,30 -109.44% | -4,65 -2,60 -78.85% | 1,03 -7,50 113.77% | 5,84 -3,75 255.56% | 9,53 0,38 2382.81% | 0,75 0,91 -17.74% | 2,40 | 4,81 | 7,09 | 8,55 | 7,02 |
|
EPS USD | Released Forecast Spread | -1,72 -0,14 -1128.57% | -1,27 -0,67 -89.55% | -0,94 -0,64 -48.03% | -0,55 -0,27 -101.22% | -0,28 -0,19 -47.37% | 0,06 -0,52 111.61% | 0,29 -0,18 265.71% | 0,45 0,04 1025% | 0,04 0,07 -40% | 0,12 | 0,26 | 0,41 | 0,50 | 0,33 |
| Announcement Date | 15/03/22 | 10/05/22 | 08/08/22 | 09/11/22 | 09/03/23 | 08/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | - | - | - | - | - |
| Today 06:25 am | ELI LILLY AND COMPANY: Q1 2024 Earnings Release |
| 2024-04-30 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 02:00 am | GSK PLC: Q1 2024 Earnings Release |
| 2024-05-01 03:00 am | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 2024-05-01 06:45 am | PFIZER, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 2024-05-01 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
Past sector events for ANI Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANIP Stock
- Calendar ANI Pharmaceuticals, Inc.
